![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, February 03, 2022 12:41:45 AM
The key is (IMO) the revenue coming in from Tollovid sales and the (looks cyclical)testing revenue. IF that revenue is close or above the burn rate for a few months it can be done. That is gonna need more of the lockup stuff (no cheating) on shares. They are spending for the AZ testing/salaries and the videssa testing/salaries. Both have GREAT market potential. But still have to get approval then sales.
I heard him talk about getting our own manuf. for Tollovid and there will be new generations of Tollovid.
PLEASE PLEASE get some country or partner to help w trials. This is good solid proven science. I really hope Israel will give EUA now w what we have. Maybe another domino or 2. C'mon Commish
FEATURED POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM
Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM